Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05276622 · ClinicalTrials.gov registry record
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Terminated
- Registry status
- 64
- Enrollment target
NCT05276622 is a clinical trial that was terminated before completion, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 64 participants.
The verdict
NCT05276622 was terminated before completion, sponsored by UNC Lineberger Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 64 participants
- Enrollment target
Study Summary
This research study is explore the impact over time of multiple myeloma and its associated treatments on the physical and cognitive function and quality of life of patients and their care partners and how these impacts affect the overall illness experience.
Interventions
- OTHER Comprehensive Geriatric Assessment
- OTHER Qualitative patient-care partner interviews
- OTHER Surveys on well-being and function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2022-02-08 |
| Est. Completion | 2023-10-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05276622
The ClinicalTrials.gov registry entry for NCT05276622 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Comprehensive Geriatric Assessment is the first listed.
NCT05276622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05276622 about?
NCT05276622 is a clinical study titled "Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)". This research study is explore the impact over time of multiple myeloma and its associated treatments on the physical and cognitive function and quality of life of patients and their care partners and how these impacts affect the overall illness experience.
What is the current status of trial NCT05276622?
This trial is currently terminated. The enrollment target is 64 participants. The study started on 2022-02-08. Estimated completion is 2023-10-03.
What interventions are being tested in trial NCT05276622?
The interventions under investigation include: Comprehensive Geriatric Assessment (OTHER), Qualitative patient-care partner interviews (OTHER), Surveys on well-being and function (OTHER).
Who is sponsoring clinical trial NCT05276622?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.